Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
5-HT 1A receptor (HTR1A) |
Target Info
|
Modulator |
[3] |
| Dopamine D2 receptor (D2R) |
Target Info
|
Modulator |
[3] |
| References |
Top |
| REF 1 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| REF 2 |
Drugs used to treat Parkinson's disease, present status and future directions. CNS Neurol Disord Drug Targets. 2008 Oct;7(4):321-42.
|
| REF 3 |
Dual ligands targeting dopamine D2 and serotonin 5-HT1A receptors as new antipsychotical or anti-Parkinsonian agents.Curr Med Chem.2014;21(4):437-57.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
